Measuring Social Communication Behaviors as a Treatment Endpoint in Individuals with Autism Spectrum Disorder

Autor/inn/en	Anagnostou, Evdokia; Jones, Nancy; Huerta, Marisela; Halladay, Alycia K.; Wang, Paul; Scahill, Lawrence; Horrigan, Joseph P.; Kasari, Connie; Lord, Cathy; Choi, Dennis; Sullivan, Katherine; Dawson, Geraldine
Titel	Measuring Social Communication Behaviors as a Treatment Endpoint in Individuals with Autism Spectrum Disorder
Quelle	In: Autism: The International Journal of Research and Practice, 19 (2015) 5, S.622-636 (15 Seiten) PDF als Volltext Verfügbarkeit
Sprache	englisch
Dokumenttyp	gedruckt; online; Zeitschriftenaufsatz
ISSN	1362-3613
DOI	10.1177/1362361314542955
Schlagwörter	Autism; Pervasive Developmental Disorders; Interpersonal Communication; Interpersonal Competence; Outcomes of Treatment; Outcome Measures; Social Behavior; Symptoms (Individual Disorders); Psychometrics; Aberrant Behavior Checklist; Communication and Symbolic Behavior Scales; Autism Diagnostic Observation Schedule; Behavior Assessment System for Children; Childhood Autism Rating Scale; Social Skills Rating System; Vineland Adaptive Behavior Scales + Suchen Sie Ihr Suchwort? Autismus; Interpersonale Kommunikation; Interpersonale Kompetenz; Social behaviour; Soziales Verhalten; Psychiatrische Symptomatik; Psychometry; Psychometrie
Abstract	Social communication impairments are a core deficit in autism spectrum disorder. Social communication deficit is also an early indicator of autism spectrum disorder and a factor in long-term outcomes. Thus, this symptom domain represents a critical treatment target. Identifying reliable and valid outcome measures for social communication across a range of treatment approaches is essential. Autism Speaks engaged a panel of experts to evaluate the readiness of available measures of social communication for use as outcome measures in clinical trials. The panel held monthly conference calls and two face-to-face meetings over 14?months. Key criteria used to evaluate measures included the relevance to the clinical target, coverage of the symptom domain, and psychometric properties (validity and reliability, as well as evidence of sensitivity to change). In all, 38 measures were evaluated and 6 measures were considered appropriate for use, with some limitations. This report discusses the relative strengths and weaknesses of existing social communication measures for use in clinical trials and identifies specific areas in need of further development. (As Provided).
Anmerkungen	SAGE Publications. 2455 Teller Road, Thousand Oaks, CA 91320. Tel: 800-818-7243; Tel: 805-499-9774; Fax: 800-583-2665; e-mail: journals@sagepub.com; Web site: http://sagepub.com
Erfasst von	ERIC (Education Resources Information Center), Washington, DC
Update	2020/1/01